Mechanisms of disease: Pain in fibromyalgia syndrome

Nature Clinical Practice Rheumatology

Volumn 2, Issue 2, 2006, Pages 90-98

  Staud, Roland ^a   Rodriguez, Miguel E ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Central sensitization, Fibromyalgia sydrome; Pain; Peripheral sensitization; Temporal summation

Indexed keywords

AMINO ACID; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; CALCIUM; MUSCLE RELAXANT AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; SUBSTANCE P;

AEROBIC EXERCISE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BEHAVIOR THERAPY; CHRONIC PAIN; COGNITIVE THERAPY; COMORBIDITY; COPING BEHAVIOR; CORRELATION COEFFICIENT; DISTRESS SYNDROME; FIBROMYALGIA; HUMAN; LIFE EVENT; MAJOR DEPRESSION; MEDLINE; NERVE CELL PLASTICITY; NERVE CELL STIMULATION; NERVE CONDUCTION; NEUROENDOCRINE SYSTEM; NOCICEPTION; NONHUMAN; PAIN; PAIN ASSESSMENT; PAIN THRESHOLD; PATHOGENESIS; PHYSIOTHERAPY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIZATION; SENSORY NERVE; SOMATIC DELUSION; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TEMPORAL SUMMATION;

AUTONOMIC NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM; FIBROMYALGIA; HUMANS; MUSCLE, SKELETAL; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; SYNDROME;

EID: 32644437449     PISSN: 17458382     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncprheum0091     Document Type: Review

References (68)

1. Wolfe F et al. (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33: 160-172
2. Russell IJ et al. (1994) Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 37: 1593-1601
3. Sorensen J et al. (1998) Hyperexcitability in fibromyalgia. J Rheumatol 25: 152-155
4. Kosek E et al. (1995) Increased pressure pain sensibility in fibromyalgia patients is located deep to the skin but not restricted to muscle tissue. Pain 63: 335-339
5. Wolfe F et al. (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38: 19-28
6. Loeser JD (1991) What is chronic pain? Theor Med 12: 213-225
7. Merskey H and Bogduk N (Eds.; 1994) Classification of chronic pain: description of chronic pain syndromes and definition of pain terms. Seattle: IASP Press
8. Bayer TL et al. (1991) Situational and psychophysiological factors in psychologically induced pain. Pain 44: 45-50
9. Graven-Nielsen T et al. (2002) Peripheral and central sensitization in musculoskeletal pain disorders: An experimental approach. Curr Rheumatol Rep 4: 313-321
10. Granot M et al. (2001) Simultaneous recording of late and ultra-late pain evoked potentials in fibromyalgia. Clin Neurophysiol 112: 1881-1887
11. Kosek E et al. (1996) Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain 68: 375-383
12. Staud R et al. (2003) Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome. Pain 102: 87-95
13. Acasuso-Diaz M et al. (1998) Topical capsaicin versus ketoprofen in primary fibromyalgia syndrome. Br J Rheumatol 37: S151
14. Reddy SS et al. (2000) Tender point injections are beneficial in fibromyalgia syndrome: A descriptive, open study. J Musculoskelet Pain 8: 7-18
15. Arendt-Nielsen L et al. (2003) Central sensitization in fibromyalgia and other musculoskeletal disorders. Curr Pain Headache Rep 7: 355-361
16. Desmeules JA et al. (2003) Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 48: 1420-1429
17. Staud R (2004) New evidence for central sensitization in patients with fibromyalgia. Curr Rheumatol Rep 6: 259
18. Simms RW (1998) Fibromyalgia is not a muscle disorder. Am J Med Sci 315: 346-350
19. Sprott H et al. (1998) Immunohistochemical and molecular studies of serotonin, substance P, galanin, pituitary adenylyl cyclase-activating polypeptide, and secretoneurin in fibromyalgic muscle tissue. Arthritis Rheum 41: 1689-1694
20. Sprott H et al. (2004) Increased DNA fragmentation and ultrastructural changes in fibromyalgic muscle fibres. Ann Rheum Dis 63: 245-251
21. Salemi S et al. (2003) Detection of interleukin 1β (IL-1β), IL-6, and tumor necrosis factor-α in skin of patients with fibromyalgia. J Rheumatol 30: 146-150
22. Graven-Nielsen T et al. (2002) Is there a relation between intramuscular hypoperfusion and chronic muscle pain? J Pain 3: 261-263
23. Wall PD et al. (1984) Muscle but not cutaneous C-afferent input produces prolonged increases in the excitability of the flexion reflex in the rat. J Physiol 356: 443-458
24. Hunt IM et al. (1999) The prevalence and associated features of chronic widespread pain in the community using the 'Manchester' definition of chronic widespread pain. Rheumatology 38: 275-279
25. Benjamin S et al. (2000) The association between chronic widespread pain and mental disorder - a population-based study. Arthritis Rheum 43: 561-567
26. Forseth KO et al. (1999) A 5.5 year prospective study of self-reported musculoskeletal pain and of fibromyalgia in a female population: significance and natural history. Clin Rheumatol 18: 114-121
27. McBeth J et al. (2001) Features of somatization predict the onset of chronic widespread pain: Results of a large population-based study. Arthritis Rheum 44: 940-946
28. Arnold LM et al. (2004) Family study of fibromyalgia. Arthritis Rheum 50: 944-952
29. Raphael KG et al. (2004) Familial aggregation of depression in fibromyalgia: A community-based test of alternate hypotheses. Pain 110: 449-460
30. Woolf CJ (1996) Windup and central sensitization are not equivalent. Pain 66: 105-108
31. Li J et al. (1999) Windup leads to characteristics of central sensitization. Pain 79: 75-82
32. Granovsky Y et al. (2005) Thermoreceptive innervation of human glabrous and hairy skin: A contact heat evoked potential analysis. Pain 115: 238-247
33. Staud R et al. (2001) Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 91: 165-175
34. Dickenson AH et al. (1987) Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology 26: 1235-1238
35. Mendell LM et al. (1965) Responses of single dorsal cord cells to peripheral cutaneous unmyelinated fibres. Nature 206: 97-99
36. Price DD et al. (1977) Peripheral suppression of first pain and central summation of second pain evoked by noxious heat pulses. Pain 3: 57-68
37. Staud R et al. (2005) Effects of the NDMA receptor antagonist dextromethorphan on temporal summation of pain are similar in fibromyalgia patients and normal controls. J Pain 6: 323-332
38. Price DD et al. (1994) The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man. Pain 59: 165-174
39. Vierck CJ et al. (1997) Characteristics of temporal summation of second pain sensations elicited by brief contact of glabrous skin by a preheated thermode. J Neurophysiol 78: 992-1002
40. Staud R (2002) Evidence of involvement of central neural mechanisms in generating fibromyalgia pain. Curr Rheumatol Rep 4: 299-305
41. Price DD et al. (2002) Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain 99: 49-59
42. Staud R et al. (2001) Evidence for abnormal pain processing in fibromyalgia syndrome. Pain Med 2: 208-215
43. Staud R et al. (2003) Ratings of experimental pain and pain-related negative affect predict clinical pain in patients with fibromyalgia syndrome. Pain 105: 215-222
44. Watkins LR et al. (2001) Glial activation: A driving force for pathological pain. Trends Neurosci 24: 450-455
45. Watkins LR et al. (2003) When good pain turns bad. Curr Dir Psycholog Sci 12: 232-236
46. Cook AJ et al. (1987) Dynamic receptive field plasticity in rat spinal cord dorsal horn following C-primary afferent input. Nature 325: 151-153
47. Bengtsson A et al. (1986) Muscle biopsy in primary fibromyalgia. Light-microscopical and histochemical findings. Scand J Rheumatol 15: 1-6
48. Bengtsson A et al. (1986) Primary fibromyalgia. A clinical and laboratory study of 55 patients. Scand J Rheumatol 15: 340-347
49. Lund N et al. (1986) Muscle tissue oxygen pressure in primary fibromyalgia. Scan J Rheumatol 15: 165-173
50. Sluka KA et al. (2001) Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve 24: 37-46
51. Park JH et al. (1998) Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles of patients with fibromyalgia. Arthritis Rheum 41: 406-413
52. Crofford LJ (2002) The hypothalamic-pituitary-adrenal axis in fibromyalgia: Where are we in 2001? J Musculoskelet Pain 10: 215-220
53. Riedel W et al. (2002) Blunted ACTH and cortisol responses to systemic injection of corticotropin-releasing hormone (CRH) in fibromyalgia: Role of somatostatin and CRH-binding protein. Ann NY Acad Sci 966: 483-490
54. Martinez-Lavin M (2002) The autonomic nervous system and fibromyalgia. J Musculoskelet Pain 10: 221-228
55. Cohen H et al. (2001) Abnormal sympathovagal balance in men with fibromyalgia. J Rheumatol 28: 581-589
56. Martinez-Lavin M et al. (1998) Circadian studies of autonomic nervous balance in patients with fibromyalgia - a heart rate variability analysis. Arthritis Rheum 41: 1966-1971
57. Crofford LJ et al. (1996) Neurohormonal perturbations in fibromyalgia. Clin Rheumatol 10: 365-378
58. Pillemer SR et al. (1997) The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum 40: 1928-1939
59. Price DD (2000) Psychological and neural mechanisms of the affective dimension of pain. Science 288: 1769-1772
60. Fields HL and Basbaum AI (1999) Central nervous system mechanisms of pain modulation. In Textbook of Pain, 309-329 (Eds Wall PD and Melzack R) Edinburgh: Churchill Livingstone
61. Gebhart GF (2004) Descending modulation of pain. Neurosci Biobehav Rev 27: 729-737
62. Lautenbacher S et al. (1997) Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain 13: 189-196
63. Julien N et al. (2005) Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 114: 295-302
64. Calejesan AA et al. (2000) Descending facilitatory modulation of a behavioral nociceptive response by stimulation in the adult rat anterior cingulate cortex. Eur J Pain 4: 83-96
65. Oliver K et al. (2001) A review of multidisciplinary interventions for fibromyalgia patients: Where do we go from here? J Musculoskelet Pain 9: 63-80
66. Sorensen J et al. (1997) Fibromyalgia - are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs. J Rheumatol 24: 1615-1621
67. Arnold LM et al. (2004) A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50: 2974-2984
68. Crofford LJ et al. (2005) Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 52: 1264-1273